These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16956897)

  • 21. Bridging therapy after recent stent implantation: case report and review of data.
    Wessler JD; Saldana F; Giugliano RP
    Cardiovasc Revasc Med; 2012; 13(1):30-8. PubMed ID: 22019210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 23. The patient with coronary stents and antiplatelet agents: what to do and how to deal?
    Bornemann H; Prüller F; Metzler H
    Eur J Anaesthesiol; 2010 May; 27(5):406-10. PubMed ID: 20009935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
    Chen TH; Matyal R
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet therapy during perioperative period: double-edged sword.
    Kozuma K
    J Cardiol; 2014 Nov; 64(5):331-3. PubMed ID: 24861910
    [No Abstract]   [Full Text] [Related]  

  • 26. A retrospective study showing the extent of compliance with perioperative guidelines in patients with coronary stents with regard to double antiplatelet therapy.
    Woolard AA; Ehrenfeld JM; Eagle SS; Wanderer JP
    J Clin Anesth; 2016 Sep; 33():179-84. PubMed ID: 27555160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subacute thrombosis after primary percutaneous coronary intervention with bioresorbable vascular scaffold implantation.
    Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A
    Kardiol Pol; 2015; 73(4):300. PubMed ID: 25892264
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiplatelet therapy for elective coronary stenting: a moving target.
    Claeys MJ
    Semin Vasc Med; 2003 Nov; 3(4):415-8. PubMed ID: 15199448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thoracic epidurals and antiplatelet therapy.
    Smith RL
    Anaesthesia; 2006 Sep; 61(9):908-9. PubMed ID: 16922768
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of stents in the current era: long-term antiplatelet therapy and late-stent thrombosis.
    Buxton B
    ANZ J Surg; 2008; 78(1-2):2-5. PubMed ID: 18199197
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term safety of drug-eluting stents.
    Riede FN; Pfisterer M; Jeger R
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1359-78. PubMed ID: 24138523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patient at risk of endocoronary stent thrombosis during perioperative period: a frequent situation].
    Lehot JJ; Piriou V; Durand de Gevigney G; Coriat P
    Ann Fr Anesth Reanim; 2005 Oct; 24(10):1247-9. PubMed ID: 16099127
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology: antiplatelet therapy during surgery.
    Möllmann H; Nef HM; Hamm CW
    Heart; 2010 Jun; 96(12):986-91. PubMed ID: 20538676
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiplatelet drugs in elective ENT surgery.
    Savage JR; Parmar A; Robinson PJ
    J Laryngol Otol; 2012 Sep; 126(9):886-92. PubMed ID: 22892218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced long-term antiplatelet therapy after coronary stenting.
    Moses JW; Shah PK
    J Invasive Cardiol; 2005 Dec; 17(12):669-76. PubMed ID: 16327052
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute profound thrombocytopenia after use of eptifibatide for coronary stenting.
    Salengro E; Mulvihill NT; Farah B
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):73-5. PubMed ID: 12508201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction.
    Chassot PG; Delabays A; Spahn DR
    Br J Anaesth; 2007 Sep; 99(3):316-28. PubMed ID: 17650517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Developments in percutaneous coronary intervention and coronary stents].
    Simsek C; Daemen J; Zijlstra F
    Ned Tijdschr Tandheelkd; 2014; 121(7-8):375-9. PubMed ID: 25174186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative antiplatelet management in patients with coronary artery stenting.
    Tandar A; Velagapudi KN; Wilson BD; Boden WE
    Hosp Pract (1995); 2012 Apr; 40(2):118-30. PubMed ID: 22615086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.